Mc Ilrath & Eck, LLC Seagen Inc. Transaction History

Mc Ilrath & Eck, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$187.64 - $206.25 $1,125 - $1,237	-6 Reduced 13.33%	39 $7,000
Q1 2023 May 08, 2023	SELL	$127.59 - $203.08 $38,021 - $60,517	-298 Reduced 86.88%	45 $9,000
Q1 2022 May 11, 2022	BUY	$119.61 - $157.85 $1,076 - $1,420	9 Added 2.69%	343 $49,000
Q3 2021 Nov 12, 2021	BUY	$142.45 - $169.82 $38,746 - $46,191	272 Added 438.71%	334 $57,000
Q1 2021 May 12, 2021	BUY	$137.51 - $190.8 $4,400 - $6,105	32 Added 106.67%	62 $9,000

Q4 2020 Feb 05, 2021	BUY	$164.63 - $211.93 $4,938 - $6,357	30 New	30 $5,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Mc Ilrath & Eck, LLC, based on Form 13F filings with the SEC.

Stay updated on Mc Ilrath & Eck, LLC with notifications on news.